摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-Pyrrolidin-1-ium-1-ylcyclopentane-1-carboxylate

中文名称
——
中文别名
——
英文名称
1-Pyrrolidin-1-ium-1-ylcyclopentane-1-carboxylate
英文别名
——
1-Pyrrolidin-1-ium-1-ylcyclopentane-1-carboxylate化学式
CAS
——
化学式
C10H17NO2
mdl
——
分子量
183.25
InChiKey
RKEFYANFQKIQCV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.9
  • 重原子数:
    13
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.9
  • 拓扑面积:
    40.5
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    6-[4-fluoro-3-(piperazin-1-ylcarbonyl)benzyl]-4,5-dimethylpyridazin-3(2H)-one 、 1-Pyrrolidin-1-ium-1-ylcyclopentane-1-carboxylate1-羟基苯并三唑N,N-二异丙基乙胺 、 Methanaminium,N-[(dimethylamino)(3H-1,2,3-triazolo[4,5-b]pyridin-3-yloxy)methylene]-N-methyl-, hexafluorophosphate(1-) 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 生成 6-(4-fluoro-3-(4-(1-(pyrrolidin-1-yl)cyclopentanecarbonyl)piperazine-1-carbonyl)benzyl)-4,5-dimethylpyridazin-3(2H)-one
    参考文献:
    名称:
    Development of substituted 6-[4-fluoro-3-(piperazin-1-ylcarbonyl)benzyl]-4,5-dimethylpyridazin-3(2H)-ones as potent poly(ADP–ribose) polymerase-1 (PARP-1) inhibitors active in BRCA deficient cells
    摘要:
    We describe an extensive SAR study in the 6-[4-fluoro-3-(substituted)benzyl]-4,5-dimethylpyridazin-3(2H)-one series which led to the identification of potent PARP-1 inhibitors, capable of inhibiting the proliferation of BRCA-1 deficient cancer cells in the low nanomolar range, and displaying >100-fold selectivity over the BRCA wild type counterparts. The series of compounds was devoid of hERG channel activity, and CYP inhibition and induction liabilities. Several analogs were stable in rat and human liver microsomes and displayed moderate rat clearance, with urinary excretion of parent as the major route of elimination. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2009.11.087
点击查看最新优质反应信息

文献信息

  • [EN] PREPARATION OF COMPLEXING AGENTS AND METAL ION COMPLEXES IN AQUEOUS MEDIA<br/>[FR] PRÉPARATION D'AGENTS COMPLEXANTS ET COMPLEXES D'IONS MÉTALLIQUES DANS DES MILIEUX AQUEUX
    申请人:MALLINCKRODT INC
    公开号:WO2007142804A2
    公开(公告)日:2007-12-13
    [EN] The invention relates to methods of preparation for bis-amide complexing agents, as well as paramagnetic metal ion complexes that include such agents. To prepare these complexing agents, a reaction mixture is formed that includes a bis-anhydride, a nitrogen-containing compound, and an aqueous solvent system. The nitrogen-containing compound reacts with the bis-anhydride in the reaction mixture to form the bis-amide complexing agent. The molar ratio of water to the nitrogen containing compound in the reaction mixture is greater than 3:1, respectively. In addition, the molar ratio of the nitrogen-containing compound to the bis-anhydride in the reaction mixture is no greater than 2.5:1, respectively. In some embodiments, a base other than the nitrogen-containing compound may be included in the reaction mixture (e.g., to buffer the reaction mixture). In some embodiments, the bis-amide complexing agent may be contacted with a paramagnetic metal ion salt to form a paramagnetic metal ion complex of the invention.
    [FR] L'invention concerne des procédés de préparation d'agents complexants de type bis-amide, ainsi que des complexes d'ions de métaux paramagnétiques qui comprennent de tels agents. Pour préparer ces agents complexants, on forme un mélange de réaction qui comprend un bis-anhydride, un composé contenant de l'azote et un système solvant aqueux. Le composé contenant de l'azote réagit avec le bis-anhydride dans le mélange de réaction pour former l'agent complexant de type bis-amide. La proportion molaire de l'eau par rapport au composé contenant de l'azote dans le mélange de réaction est supérieure à 3:1, respectivement. En plus, la proportion molaire du composé contenant de l'azote par rapport au bis-anhydride dans le mélange de réaction est inférieure ou égale à 2,5:1, respectivement. Dans certains modes de réalisation, une base autre que le composé contenant de l'azote peut être incluse dans le mélange de réaction (par exemple pour tamponner le mélange de réaction). Dans certains modes de réalisation, on peut mettre en contact l'agent complexant de type bis-amide avec un sel d'un ion d'un métal paramagnétique pour former un complexe d'un ion d'un métal paramagnétique de l'invention.
  • Development of substituted 6-[4-fluoro-3-(piperazin-1-ylcarbonyl)benzyl]-4,5-dimethylpyridazin-3(2H)-ones as potent poly(ADP–ribose) polymerase-1 (PARP-1) inhibitors active in BRCA deficient cells
    作者:Federica Ferrigno、Danila Branca、Olaf Kinzel、Samuele Lillini、Laura Llauger Bufi、Edith Monteagudo、Ester Muraglia、Michael Rowley、Carsten Schultz-Fademrecht、Carlo Toniatti、Caterina Torrisi、Philip Jones
    DOI:10.1016/j.bmcl.2009.11.087
    日期:2010.2
    We describe an extensive SAR study in the 6-[4-fluoro-3-(substituted)benzyl]-4,5-dimethylpyridazin-3(2H)-one series which led to the identification of potent PARP-1 inhibitors, capable of inhibiting the proliferation of BRCA-1 deficient cancer cells in the low nanomolar range, and displaying >100-fold selectivity over the BRCA wild type counterparts. The series of compounds was devoid of hERG channel activity, and CYP inhibition and induction liabilities. Several analogs were stable in rat and human liver microsomes and displayed moderate rat clearance, with urinary excretion of parent as the major route of elimination. (C) 2009 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物